Literature DB >> 19141089

Prevention of ischemia/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxdiase 1.

Zhongyi Chen1, Chu C Chua, Jinping Gao, Kao-Wei Chua, Ye-Shih Ho, Ronald C Hamdy, Balvin H L Chua.   

Abstract

Free-radical generation is one of the primary causes of myocardial ischemia/reperfusion (I/R) injury. Melatonin is an efficient free-radical scavenger and induces the expression of antioxidant enzymes. We have previously shown that melatonin can prevent free-radical-induced myocardial injury. To date, the mechanism underlying melatonin's cardioprotective effect is not clear. In this study, we assessed the ability of melatonin to protect against I/R injury in mice deficient in glutathione peroxidase 1 (Gpx1). Mice hearts were subjected to 40 min of global ischemia in vitro followed by 45 min of reperfusion. Myocardial I/R injury (expressed as % of recovery of left ventricular developed pressure x heart rate) was exacerbated in mice deficient in Gpx1 (51 +/- 3% for Gpx1+/+ mice versus 31 +/- 6% for Gpx1(-/-) mice, P < 0.05). Administration of melatonin for 30 min protected against I/R injury in both Gpx1+/+ mice (72 +/- 4.8%) and Gpx1(-/-) mice (63 +/- 4.7%). This protection was accompanied by a significant improvement in left ventricular end-diastolic pressure and a twofold decrease in lactate dehydrogenase (LDH) level released from melatonin-treated hearts. In another set of experiments, mice were subjected to 50 min of ligation of the left descending anterior coronary artery in vivo followed by 4 hr of reperfusion. The infarct sizes, expressed as the percentage of the area at risk, were significantly larger in Gpx1(-/-) mice than in Gpx1+/+ mice (75 +/- 9% versus 54 +/- 6%, P < 0.05) and were reduced significantly in melatonin-treated mice (31 +/- 3.7% Gpx1(-/-) mice and 33 +/- 6.0% Gpx1+/+ mice). In hearts subjected to 30 min of coronary artery occlusion followed by 3 hr of reperfusion, melatonin-treated hearts had significantly fewer in situ oligo ligation-positive myocytes and less protein nitration. Our results demonstrate that the cardioprotective function of melatonin is independent of Gpx1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19141089      PMCID: PMC2752734          DOI: 10.1111/j.1600-079X.2008.00654.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  37 in total

1.  Melatonin protects the heart against both ischemia/reperfusion injury and chemotherapeutic drugs.

Authors:  Russel J Reiter; Dun-Xian Tan; Rosa M Sainz; Juan C Mayo
Journal:  Cardiovasc Drugs Ther       Date:  2002-01       Impact factor: 3.727

2.  Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice.

Authors:  Chu Chang Chua; Jinping Gao; Ye-Shih Ho; Xingshun Xu; I-Chun Kuo; Kaw-Yan Chua; Hong Wang; Ronald C Hamdy; John C Reed; Balvin H L Chua
Journal:  Cardiovasc Res       Date:  2008-09-18       Impact factor: 10.787

3.  Effects of melatonin on ischemia and reperfusion injury of the rat heart.

Authors:  O Szárszoi; G Asemu; J Vanecek; B Ost'ádal; F Kolár
Journal:  Cardiovasc Drugs Ther       Date:  2001       Impact factor: 3.727

4.  Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice.

Authors:  Z Chen; C C Chua; Y S Ho; R C Hamdy; B H Chua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

5.  Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart.

Authors:  C Lagneux; M Joyeux; P Demenge; C Ribuot; D Godin-Ribuot
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

Review 6.  Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart.

Authors:  Russel J Reiter; Dun-Xian Tan
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

7.  Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation.

Authors:  D X Tan; L C Manchester; R J Reiter; B F Plummer; J Limson; S T Weintraub; W Qi
Journal:  Free Radic Biol Med       Date:  2000-12       Impact factor: 7.376

8.  Melatonin protects against ischaemic-reperfusion myocardial damage.

Authors:  R Salie; I Harper; C Cillie; S Genade; B Huisamen; J Moolman; A Lochner
Journal:  J Mol Cell Cardiol       Date:  2001-02       Impact factor: 5.000

9.  Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin.

Authors:  Engin Sahna; Ahmet Acet; M Kaya Ozer; Ercument Olmez
Journal:  J Pineal Res       Date:  2002-11       Impact factor: 13.007

10.  Melatonin as an effective protector against doxorubicin-induced cardiotoxicity.

Authors:  Xuwan Liu; Zhongyi Chen; Chu Chang Chua; Yan-Shan Ma; George A Youngberg; Ronald Hamdy; Balvin H L Chua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

View more
  19 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Glutathione peroxidase 1 protects mitochondria against hypoxia/reoxygenation damage in mouse hearts.

Authors:  Vu Thi Thu; Hyoung Kyu Kim; Seung Hee Ha; Ji-Young Yoo; Won Sun Park; Nari Kim; Goo Taeg Oh; Jin Han
Journal:  Pflugers Arch       Date:  2010-03-20       Impact factor: 3.657

Review 3.  Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy.

Authors:  Daniel San-Martín-Martínez; Dayanara Serrano-Lemus; Vicente Cornejo; Abraham I J Gajardo; Ramón Rodrigo
Journal:  Clin Pharmacokinet       Date:  2022-07-25       Impact factor: 5.577

Review 4.  Melatonin as a protective agent in cardiac ischemia-reperfusion injury: Vision/Illusion?

Authors:  Puneet Kaur Randhawa; Manish Kumar Gupta
Journal:  Eur J Pharmacol       Date:  2020-08-26       Impact factor: 4.432

Review 5.  Roles of melatonin and its receptors in cardiac ischemia-reperfusion injury.

Authors:  Kodchanan Singhanat; Nattayaporn Apaijai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2018-08-13       Impact factor: 9.261

6.  Protective effect of N-acetylserotonin against acute hepatic ischemia-reperfusion injury in mice.

Authors:  Shuna Yu; Jie Zheng; Zhengchen Jiang; Caixing Shi; Jin Li; Xiaodong Du; Hailiang Wang; Jiying Jiang; Xin Wang
Journal:  Int J Mol Sci       Date:  2013-08-29       Impact factor: 5.923

7.  Melatonin Prevents Mitochondrial Damage Induced by Doxorubicin in Mouse Fibroblasts Through Ampk-Ppar Gamma-Dependent Mechanisms.

Authors:  Celal Guven; Eylem Taskin; Handan Akcakaya
Journal:  Med Sci Monit       Date:  2016-02-10

Review 8.  Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties.

Authors:  Mohammad Hossein Pourhanifeh; Ehsan Dehdashtian; Azam Hosseinzadeh; Seyed Hashem Sezavar; Saeed Mehrzadi
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-14       Impact factor: 3.727

9.  Effect of limb ischemic preconditioning on myocardial apoptosis-related proteins in ischemia-reperfusion injury.

Authors:  Jianzhi Gao; Linjing Zhao; Yongling Wang; Qinglei Teng; Lidong Liang; Jinying Zhang
Journal:  Exp Ther Med       Date:  2013-02-26       Impact factor: 2.447

10.  Melatonin modulates endoplasmic reticulum stress and Akt/GSK3-beta signaling pathway in a rat model of renal warm ischemia reperfusion.

Authors:  Kaouther Hadj Ayed Tka; Asma Mahfoudh Boussaid; Mohamed Amine Zaouali; Rym Kammoun; Mohamed Bejaoui; Sonia Ghoul Mazgar; Joan Rosello Catafau; Hassen Ben Abdennebi
Journal:  Anal Cell Pathol (Amst)       Date:  2015-07-01       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.